Fundamental analysis QMSMEDI.NS (QMS Medical Allied Services Limited)
Updated on 10/15/2026
Method and analysis by Lubin Danilo, founder of Lubin Investment. Score computed automatically, with no human opinion.
We analyzed QMS Medical Allied Services stock against the 10 quality criteria of Lubin Investment. The company gets a quality score of 7/10, meaning medium quality, and a P/FCF valuation multiple of 16.3×.
This is the setup we look for: QMS Medical Allied Services passes a large majority of our quality criteria while trading at a low free cash flow multiple. That is exactly the "quality company at the right price" profile, the one worth a closer look.
Sector: Medical Instruments & Supplies. Listing: NS. Current price: 169.00 INR.
Lubin scoring methodology
QMS Medical Allied Services Limited (QMSMEDI.NS)'s score is calculated automatically from 10 objective financial criteria, with no human intervention or opinion. Each criterion is validated (YES / PARTIAL / NO) based on thresholds drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran). The final score is the sum of validations.
The thresholds come from the financial literature, not from our preferences: see the valuation work of Aswath Damodaran (NYU Stern) and the SEC investor education resources (investor.gov).
The 10 quantitative criteria analyzed
- Profitable: net margin > 5%
- Growing revenue: revenue growing > 10%/year over 5 years
- Growing earnings per share: FCF per share adjusted for stock-based compensation, > 10%/year over 5 years
- Share count under control: stable or declining (net buybacks = value creation for shareholders)
- Growing revenue per employee: revenue and revenue per employee both grow ≥ 10%/year over 5 years; partial when only one growth driver reaches its tier (fallback: free cash flow margin > 10% when employee history is unavailable)
- Expanding margins: operating margin widens over 5 years (operating leverage)
- Return on invested capital: Cash ROCE > 15% per year
- Debt under control: net debt repayable in less than 3 years of free cash flow
- Earnings converted to cash: free cash flow exceeds accounting net income
- Net collection period: short or negative cash conversion cycle
Its price against peers
Against the 5 other Medical Instruments & Supplies stocks we have scored, QMS Medical Allied Services trades at 16.3× its free cash flow, versus a median of 26.1× for that basket. On price alone, QMS Medical Allied Services is therefore cheaper than its peers. That says nothing about its quality: at Lubin Investment, quality and price are judged separately, and a low multiple is only a bargain if the quality holds up.
Frequently asked questions
Is QMS Medical Allied Services a quality stock?
QMS Medical Allied Services gets a quality score of 7/10 (medium quality), calculated over the 10 Lubin Investment criteria: profitability, revenue and free cash flow growth, share buybacks, margins, debt and return on capital.
How is QMS Medical Allied Services's score calculated?
The score is the total of validated criteria (YES / PARTIAL / NO) using thresholds drawn from the financial literature (Warren Buffett, Mauboussin, Aswath Damodaran), automatically and with no human opinion.
What is QMS Medical Allied Services's P/FCF?
The price-to-free-cash-flow (P/FCF) multiple of QMS Medical Allied Services stock is 16.3×. At Lubin Investment, valuation is judged separately from quality.
Where to see QMS Medical Allied Services's full analysis?
The full interactive analysis (10-criteria detail, history, P/FCF valuation, sector comparisons) is available at https://lubin-investment.com/analyse/QMSMEDI.NS?lng=en.
Other stocks in the Medical Instruments & Supplies sector
- Resmed (RMD), score 10/10, P/FCF 19.8×
- Asahi Intecc (7747.T), score 10/10, P/FCF 30.8×
- ResMed (RMD.AX), score 9/10, P/FCF 28.0×
- LeMaitre Vascular (LMAT), score 9/10, P/FCF 26.1×
Go further
👉 See the full interactive analysis of QMSMEDI.NS
Other resources : All stocks in the Medical Instruments & Supplies sector.